Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma

No biomarkers are available to predict relative clinical benefit from targeted therapies in patients with non-clear cell renal cell carcinoma (nccRCC). To identify candidate predictive markers, we investigated a set of cytokines and angiogenic factors (CAFs) in previously untreated patients with ncc...

Descripción completa

Detalles Bibliográficos
Autores principales: Msaouel, Pavlos, Zurita, Amado J., Huang, Shixia, Jonasch, Eric, Tannir, Nizar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522056/
https://www.ncbi.nlm.nih.gov/pubmed/28178674
http://dx.doi.org/10.18632/oncotarget.15011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522056/
https://www.ncbi.nlm.nih.gov/pubmed/28178674
http://dx.doi.org/10.18632/oncotarget.15011

Ejemplares similares